Recent News

• 03.05.2025 - MBX Biosciences Announces Additions to Leadership Team
• 03.05.2025 - MBX Biosciences Announces Additions to Leadership Team
• 03.03.2025 - March 3, 2025 10:30 AM EST - March 3, 2025 11:00 AM EST : TD Cowen 45th Annual Healthcare Conference
• 03.03.2025 - March 3, 2025 10:30 AM EST - March 3, 2025 11:00 AM EST : TD Cowen 45th Annual Healthcare Conference
• 03.03.2025 - MBX Biosciences Completes Enrollment in Phase 2 Avail™ Trial of MBX 2109 (Canvuparatide) for Hypoparathyroidism
• 03.03.2025 - MBX Biosciences Completes Enrollment in Phase 2 Avail™ Trial of MBX 2109 (Canvuparatide) for Hypoparathyroidism
• 02.18.2025 - MBX Biosciences to Participate in March Investor Conferences
• 02.18.2025 - MBX Biosciences to Participate in March Investor Conferences
• 02.11.2025 - February 11, 2025 8:40 AM EST - February 11, 2025 9:10 AM EST : Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual)
• 02.11.2025 - February 11, 2025 8:40 AM EST - February 11, 2025 9:10 AM EST : Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual)

Recent Filings

• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities